FGFR1 and lymphoma: Among them, only four were fusion transcripts previously described in T-cell lymphoblastic leukaemia/lymphoma (RIC3-TRBC2, PICALM-MLLT10, MLLT10-PICALM, and ZMYM2-FGFR1), but most of them are absolutely novel not only in T-cell lymphoblastic neoplasms but also in any type of cancer.